Mr. Richard Heinzl reports

ASEP MEDICAL HOLDINGS INC. APPOINTS MR. PAUL KANIA TO ITS BOARD OF DIRECTORS

ASEP Medical Holdings Inc. has appointed Paul Kania to its board of directors, effective immediately.

Mr. Kania brings more than 20 years of experience in accounting, finance and corporate governance to ASEP. He is the founder of PLK Accounting & Finance Inc., a firm that provides C-suite leadership and board advisory services to both private and publicly traded companies.

Prior to founding PLK, Mr. Kania built an impressive career with leading financial and professional services organizations. He worked as an auditor with MNP LLP in Toronto and Berdon LLP in New York before joining Brookfield Asset Management, where he served as a manager within the company's corporate finance department.

"Paul's extensive financial expertise, public company experience and strong understanding of corporate governance will be invaluable as the company continues to advance its strategic objectives," said Richard Heinzl, interim chief executive officer of ASEP. "We are delighted to welcome him to our board and look forward to benefiting from his insight and leadership."

Mr. Kania holds a bachelor of arts (honours) in economics and philosophy from the University of Toronto and a finance and accounting certificate from Toronto Metropolitan University. He is also an unregistered certified public accountant with the State of New York.

"I am excited to join ASEP's board of directors at such an important stage in the company's growth," said Mr. Kania. "The company has the potential to address critical health care challenges, and I look forward to supporting its mandate as it works to create value for patients, partners and shareholders."

The appointment reflects ASEP's continued commitment to strengthening its leadership team and governance capabilities as the company advances its mission to improve outcomes for patients affected by sepsis and other life-threatening infections.

ABOUT ASEP Medical Holdings Inc.

ASEP Medical Holdings is a standout biotechnology research and development company based in Victoria, B.C., Canada. The company possesses a valuable portfolio of global patents for innovative diagnostic and therapeutic medical technologies. These technologies were developed over the past decade at the University of British Columbia under the guidance of Dr. Robert E.W. Hancock, one of the world's foremost microbiologists. ASEP holds a controlling interest in two private subsidiary companies -- Sepset Biosciences (ASEP's leading product, a sepsis diagnostic technology) and ABT Innovations (specializing in anti-biofilm technology). As the company's patented innovations address unmet medical needs, it presents a unique investment opportunity for both retail and institutional investors.

We seek Safe Harbor.